Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in the United States and worldwide, accounting for about 22 percent of newly diagnosed cases of B-cell …

B-cell-like (GCB): The most common subtype. Generally, it appears in the lymph node bu can also appear in other parts of the body. It is an aggressive lymphoma, but patients may have a greater …

Cancer cell morphology: looking at the cancer cells under the microscope to examine their shape, structure, and form. Cancer markers: using special methods (like immunohistochemistry and flow …

Diffuse Large B-Cell Lymphoma: Relapsed/Refractory most common form of non-Hodgkin lymphoma (NHL), accounting for about 1 out of spleen, liver, and bone marrow (the spongy tissue inside the …

Treatment Options Since DLBCL can advance quickly, it usually requires immediate treatment. A combination of chemotherapy and the monoclonal antibody rituximab (Rituxan), with or without …

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type: This lymphoma usually appears as solitary or multiple tumor nodules on the legs, arms, and/or torso and is less common but usually …

HGBL, not otherwise specified (NOS). This subtype includes aggressive B-cell lymphomas with mixed characteristics of other types of B-cell lymphoma such as DLBCL, Burkitt lymphoma (BL), blastoid …

On January 12th, 2023, I got the call from my primary care provider with the biopsy results: I was diagnosed with T-cell/histiocyte-rich B-cell lymphoma, an uncommon variant of diffuse large B-cell …

High-dose chemotherapy followed by stem cell transplantation can be used to treat patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Diffuse Large B-Cell Lymphoma is an aggressive type of non-Hodgkin lymphoma that can arise in lymph nodes or outside of the lymphatic system.